2012-05-16 14:09 GöteborgBIO CYTO365 won the “Best business plan"-award, at the Venture Cup Väst (West) regional final held in Gothenburg on 10 May. The company has patented a safe new valve, “CYTO365", which prevents thrombosis and air embolism in patients during chemotherapy treatment.Velit Biologics, develops SB101, a new cancer drug which chokes tumours by cutting off their nutrients via blood vessels.






